Table: begin end state 1 1603 non-cytoplasmic
Input: >WP_011382479.1 MEISAYLDRRIAELSEPLAKVGAGRLIRAYAAGIPLADLAEADPELVYGAALGLFAFLRD RQPGAPSIRVFDPDLDRHGWVSSHSVVEIINDDMPFLVDSVAMELARRGIKVHLLVHPVL RVDRDGAGTLVQVAANGSGSTPESVMHVEIDRQPAEVQTQLAESLAEVLAQVRLAVADWR RMLETLWAGVTEFENASAKVPADEKQEALAFLEWLADNHFTFLGYRRFDLAKGVVADPAS GLGILSDAGAHVFDDTVTLADMPAELRAFVQRPDPLMVTKSARHAVIHRPVRMDIIGLKQ FDAKGKVVGLHAFLGLFTSAAYNDRPAQIPLLRRKIARVEARADFNKSGHDAKALINILE TYPRDELFQVSEDALFEISIGILHLQDRQRVAVFLRNDEFERFVSCLVFVPRDRYDTPLR LAVTAMLEEALGGTLDTFYTQVADLPLARLHFIIRTTPGHLRRVDALALEVRIADAARTW HEHLQDALIQTHGEAAGLALARRWGKGFPASYRESHGALAAVADVGRIQTASGGDIVLNL YRPVEAEPRQGRLKLYRSGQPVPLSGILPMLEAMGLVVIAEVPHEIEPDSGGSTVWIHDF EVESADGAPLDVAERRELFHDALAAVWRGDADSDGFNRLVLSAGLSWREIMVLRAYTKYL RQTGITYSQTYIEQALGGNADMATGLVRLFLASFDPKGRSGDASEAEAALLAGLDKVVSA DDDRILRRFLNLIRSTLRTNYFQTDGAGKPKAYLSFKLDSRQVDDLPAPRPLVEVFVYSP RVEAIHLRGGKVARGGIRWSDRREDFRTEILGLMKAQMVKNAVIVPVGAKGGFVVKKPPA AGGREAYMAEGIECYKTLMRGLLDLTDNLVPEGVRPPPDVLRRDGDDPYLVVAADKGTAT FSDIANAVSLEYGHWLGDAFASGGSQGYDHKKMGITAKGAWVAVERHFREMGIDTRSEDF TVIGVGDMSGDVFGNGLLRSPHAKLVAAFNHAHIFLDPDPDPQKTFTERERLFNAVKAWP DYDLSTISPGGGIWPRSAKSIPISPQAKARFGIEANSLTPTELIRTLLKAPVDLLFLGGI GTYVKASGESNADAGDRANDTLRVNGSEVGARVVGEGANLGFTQLGRIEYAISGAGGGGG RIDTDAIDNSAGVDCSDHEVNIKILVNDLVAAGDLTPKQRDKLLAEMTGEVGALVLRDNY LQTQAISMLEAQGADLLDAEARFMRLLEKGGRLDRAIEFLPTDETLTERAARKQGFTRPE LAVLLAYGKIWLYDHILASELPDDPFMAIDLTNYFPTQLRDRFGHEIQRHRLRREIVATV VTNSIVNRVGGAFVSELMETTGHPPAQVARAYIVARDAFRMREVWRAIEELDGKVPAAAQ TAMQNEANRLVERATLWVLRSMPSPFALGAGISELSPGVKALEGAVPAILPPDAAAAVLA RIDHFVGQGVPHDLAQRVGNLIVLASAADILRIATRQNLSIETAGRLYFAVGARFSLGWL RASAEKLSGRGHWLKLAAAAAIEDLYGHQRDITSVVAASYPDLEPDAAVQAWLEANRAAV ERAETLLAELKAASHIDLSMIMVANRQLRTLTESGVAVSGGNG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server